Starling Oncology, Inc. (STLN)
Data as of Nov 2, 4:00 PM ETPrices may be delayedHow our data works
Res / Sup are automatic swing levels for educational reference only — not signals or advice.
Prices may be delayed. For informational purposes only — not investment advice.
STLN key stats
STLN GlowScore: Quiet
A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.
About Starling Oncology, Inc.
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
What's moving STLN today
Updated November 3, 2026As of November 3, 2026, Starling Oncology, Inc. (STLN) stock fell to $6.25, down 4.29% (-$0.28) versus the previous close. On the day, shares have traded between $6.23 and $6.53. That puts STLN in the upper third of its 52-week range of $2.32 to $7.13. Starling Oncology, Inc. operates in the services-offices & clinics of doctors of medicine space and carries a market capitalization of roughly $665.51 million, with about 1.46 million shares changing hands.
Latest STLN news
- Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference CallYahoo Finance· Oct 26, 9:00 AM ET
- Starling Oncology (STLN) Stock Gets Fair Value Boost On Capitated Revenue And Nexus ViewsYahoo Finance· Oct 15, 7:22 PM ET
- Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference ParticipationYahoo Finance· Oct 1, 4:14 PM ET
- Starling Oncology to Participate in Wells Fargo Healthcare ConferenceYahoo Finance· Aug 24, 9:00 AM ET
- Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at ScaleYahoo Finance· Aug 17, 8:00 AM ET
- Oncology Institute Q2 Earnings Call Highlightsmarketbeat.com· Aug 7, 2:04 PM ETTOI
- The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue EstimatesYahoo Finance· Aug 6, 7:10 PM ET
- Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 GuidanceYahoo Finance· Aug 6, 4:14 PM ET
Source: Yahoo Finance RSS · Updated November 3, 2026
Want STLN headlines, alerts and AI research in one place? Create a free account →
STLN buzz on Stocktwits
815 watchers$STLN Excited for their earnings. Trend has been great for value based care and healthcare
@Vassara· Nov 3, 6:18 AM ET
$STLN Needham Maintains Buy on Starling Oncology, Raises Price Target to $9 Benzinga 05:46 AM EDT, 10/14/2026
@speculator· Oct 14, 7:28 AM ET
$STLN Welcome new Bag Holders 😂
@SilverSurfer1111· Oct 13, 12:12 PM ET· Bearish
$STLN United Health commentary so positive for these guys
@Vassara· Oct 13, 6:12 AM ET
$STLN Serves a population of approximately 2.1 million patients across five states.^
@Georgia80· Oct 12, 9:43 PM ET· Bullish
Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →
STLN Congress & insider trades
Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.
AI research on STLN
Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.
Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.